FDA Investigator Patricia A Clark
Patricia A Clark has inspections in 1 countries as of 09 Jun 2022. Patricia A Clark has collaborated with a combined 704 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
09 Jun 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan R Condon,
Alice C Silva,
Anthony N Onianwa,
Carolyn J Cook,
Courtney N Long,
Daniel L Aisen,
David A Carlson,
Donald G Gordon,
Elizabeth B Griffin,
Ellen P Madigan,
Evelyn Taha,
Garry H Stewart,
George C Amedro,
Harry J Brewer,
Hoimay Chan,
Irina Gaberman,
Jacqueline S Warner,
James D Bridges,
Jeanette L Mcginnis,
John A Podsadowski,
Joseph J Vannelli,
Karan L Blum,
Karen L Kosar,
Kent A Conforti,
Lauren E Blaser,
Linda M Sacco,
Lorayne A Mcguinness,
Marlene L Davis,
Mary T Carden,
Matthew D Schnittker,
Michael A Charles,
Nancy L Neiger,
Nicholas C Mendiola,
Paul E Stein,
Peter Abel,
Russ E Davis,
Scott R Izyk,
Sherry M Nisson,
Steven J Libal,
Sylvia A Craven,
Tammy S Notto,
William C Lubas
Patricia A Clark's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2000 | FDA 483 | Ortho-Clinical Diagnostics - Form 483, 2000-07-20 |
April, 2000 | FDA 483 | Ortho Clinical Diagnostics - Form 483, 2000-04-14 |
February, 2000 | FDA 483 | Praxair Inc. - Form 483, 2000-02-25 |
July, 2000 | EIR | Ortho Clinical Diagnostics - EIR, 2000-07-20 |
February, 2000 | EIR | Praxair Inc. - EIR, 2000-02-25 |
February, 2000 | FDA 483 Response | Praxair Inc. - Form 483R, 2000-02-25 |
April, 2000 | EIR | Ortho-Clinical Diagnostics - EIR, 2000-04-12 |
April, 2000 | EIR | Ortho-Clinical Diagnostics - EIR, 2000-05-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more